Rapid Micro Biosystems (RPID) Cash from Investing Activities (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Cash from Investing Activities data on file, last reported at $8.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 19.52% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $12.2 million (down 63.8% YoY), and the FY2025 full-year result was $14.3 million, down 60.91% from the prior year.
• Cash from Investing Activities improved to $8.6 million in Q1 2026, from $3.9 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $24.8 million in Q2 2024 to a low of -$99.5 million in Q1 2022.
• A 5-year average of $486235.3 and a median of $8.6 million in 2026 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities tumbled 1846.41% in 2022 and jumped 508.63% in 2023, its largest moves.
• Tracing RPID's Cash from Investing Activities over 5 years: stood at $12.8 million in 2022, then decreased by 21.81% to $10.0 million in 2023, then sank by 51.41% to $4.9 million in 2024, then slipped by 20.07% to $3.9 million in 2025, then soared by 121.15% to $8.6 million in 2026.
• Business Quant data shows RPID's Cash from Investing Activities at $8.6 million in Q1 2026, $3.9 million in Q4 2025, and -$9.6 million in Q3 2025.